中慧生物-B(02627)与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议

智通财经03-13

智通财经APP讯，中慧生物-B(02627)发布公告，公司与沃森生物香港有限公司(香港沃森)订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。本次海外拓展的核心产品为集团自主研发的三价亚单位流感疫苗(惠尔康欣3)。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2619193398?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-13 17:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619193398","market":"sh","top_or_hot":-1,"title":"中慧生物-B(02627)与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议","media":"智通财经","content":"<div>\n<p>智通财经APP讯，中慧生物-B(02627)发布公告，公司与沃森生物香港有限公司(香港沃森)订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。本次海外拓展的核心产品为集团自主研发的三价亚单位流感疫苗(惠尔康欣3)。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1413676.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中慧生物-B(02627)与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中慧生物-B(02627)与香港沃森订立有关亚单位流感疫苗海外市场拓展的战略合作协议\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-13 17:49 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1413676.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，中慧生物-B(02627)发布公告，公司与沃森生物香港有限公司(香港沃森)订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。本次海外拓展的核心产品为集团自主研发的三价亚单位流感疫苗(惠尔康欣3)。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1413676.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1413676.html","article_id":"2619193398","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619193398","pubTimestamp":1773395345,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中慧生物-B 发布公告，公司与沃森生物香港有限公司订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为，香港沃森是海外业务拓展的先行者，拥有丰富的国际化运营经验。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02627":"中慧生物-B"},"translate_title":"Zhonghui Bio-B (02627) entered into a strategic cooperation agreement with Hong Kong Watson in relation to overseas market expansion of subunit influenza vaccine","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02627":1.5},"content_text":"智通财经APP讯，中慧生物-B(02627)发布公告，公司与沃森生物香港有限公司(香港沃森)订立有关亚单位流感疫苗海外市场拓展的战略合作协议。根据战略合作协议，双方将就集团研发产品的海外市场注册、销售及商业化开展深度合作。本次海外拓展的核心产品为集团自主研发的三价亚单位流感疫苗(惠尔康欣3)。该产品已于2026年一月获准上市，是中国首个且唯一适用于6月龄及以上全人群的三价亚单位流感疫苗。董事会认为，香港沃森是海外业务拓展的先行者，拥有丰富的国际化运营经验。透过本次合作，公司将借助香港沃森生物多年深耕积累的海外市场资源及成熟完善的分销网络，加快推动产品进军东南亚、拉丁美洲、中东及南半球其他地区市场。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619193398","isCrawlerRequest":true}